| Literature DB >> 28948895 |
Julie L Eiseman1,2, Michael Sciullo3, Hong Wang4, Jan H Beumer1,5,6, Charles C Horn3,7,8,9.
Abstract
Several cancer chemotherapies cause nausea and vomiting, which can be dose-limiting. Musk shrews are used as preclinical models for chemotherapy-induced emesis and for antiemetic effectiveness. Unlike rats and mice, shrews possess a vomiting reflex and demonstrate an emetic profile similar to humans, including acute and delayed phases. As with most animals, dosing of shrews is based on body weight, while translation of such doses to clinically equivalent exposure requires doses based on body surface area. In the current study body surface area in musk shrews was directly assessed to determine the Meeh constant (Km) conversion factor (female = 9.97, male = 9.10), allowing estimation of body surface area based on body weight. These parameters can be used to determine dosing strategies for shrew studies that model human drug exposures, particularly for investigating the emetic liability of cancer chemotherapeutic agents.Entities:
Keywords: body surface area; dosage; emesis; musk shrew; refinement
Mesh:
Substances:
Year: 2017 PMID: 28948895 PMCID: PMC5654602 DOI: 10.1177/0023677217695851
Source DB: PubMed Journal: Lab Anim ISSN: 0023-6772 Impact factor: 2.471